Alcohol effects on diffusing capacity of the lung for carbon monoxide (DLCO) in healthy subjects and in COPD patients Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010
The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016
Decreased levels of bis-S-bimane in exhaled breath condensate of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012
Carbon monoxide pollution is associated with decreased lung function in asthmatic adults Source: Eur Respir J 2010; 35: 266-272 Year: 2010
The importance of measuriing exhaled carbon monoxide in asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003
Exhaled carbon monoxide as a marker of tobacco exposure: is it possible to use the same parameters in COPD patients? Source: Eur Respir J 2006; 28: Suppl. 50, 389s Year: 2006
Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008
Effect of the presence of lung cancer on diffusion capacity of carbon monoxide in a cohort of smokers Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010
Smoking status in patiets with COPD and Asthma: A comparison of self-reported behavior with exhaled carbon monoxide Source: Eur Respir J 2002; 20: Suppl. 38, 577s Year: 2002
Exhaled carbon monoxide is decreased in interstitial lung diseases (ILD) Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001
Increased inflammatory markers in the exhaled breath condensate of cigarette smokers Source: Eur Respir J 2003; 21: 589-593 Year: 2003
Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004
Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006
Smoking and exhaled NO concentration in patients with COPD Source: Annual Congress 2010 - COPD: diagnosis Year: 2010
Biomarker reproducibility study in exhaled breath and induced sputum in nonsmokers, smokers and COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 77s Year: 2003
Exhaled carbon monoxide according to daily cigarette consumption in healthy smokers Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions Year: 2011
Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015